GlassScriptPhysician profile
Olujimi A Ajijola
NPI 1467589812
$159,332.00
in general payments reported to CMS, 2019-2025
13 companies · $38K in 2025
The $38K reported for 2025 was more than what 94% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,346 · 2020: $12K · 2021: $19K · 2022: $17K · 2023: $45K · 2024: $22K · 2025: $38K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $57K · Travel and Lodging: $19K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Food and Beverage: $6,914 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,950 · Honoraria: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $57,456.25 |
| Travel and Lodging | $19,008.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,987.50 |
| Food and Beverage | $6,914.35 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,950.00 |
| Honoraria | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $37,151.27 | 2019-2025 | Carto 3 |
| Abbott Laboratories | $30,443.29 | 2019-2025 | Gallant, Endurity, Ensite |
| Boston Scientific Corporation | $29,494.88 | 2023-2025 | General - Therapies, Farapulse, Clinical Trial Product |
| Medtronic, INC. | $23,289.10 | 2021-2024 | Micra, Aurora Ev-Icd Mri Surescan, Pulseselect |
| Medical Device Business Services, INC. | $14,025.70 | 2023-2024 | Carto 3 |
| Merck Sharp & Dohme LLC | $11,135.00 | 2020-2021 | |
| Biotronik INC. | $6,235.03 | 2022-2025 | Acticor 7 Vr-T Dx |
| Altathera Pharmaceuticals LLC | $3,574.03 | 2023-2024 | Sotalol Hydrochloride |
| Atricure, INC. | $2,000.00 | 2023 | |
| Medtronic Vascular, INC. | $1,500.00 | 2020 | |
| Penumbra, INC. | $234.54 | 2022 | |
| Cardiva Medical, INC. | $164.64 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Cvrx, INC. | $84.52 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olujimi Ajijola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.